The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog

por Long, Heather M., Meckiff, Benjamin J., Taylor, Graham S.
Publicado 2019

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

por Dowell, Alexander C., Haigh, Tracey A., Ryan, Gordon B., Turner, James E., Long, Heather M., Taylor, Graham S.
Publicado 2021

T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display

por Mackay, Laura K., Long, Heather M., Brooks, Jill M., Taylor, Graham S., Leung, Carol S., Chen, Adrienne, Wang, Fred, Rickinson, Alan B.
Publicado 2009

Epstein-Barr Virus Evades CD4(+) T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2

por Zuo, Jianmin, Thomas, Wendy A., Haigh, Tracey A., Fitzsimmons, Leah, Long, Heather M., Hislop, Andrew D., Taylor, Graham S., Rowe, Martin
Publicado 2011

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

por Brooks, Jill M., Long, Heather M., Tierney, Rose J., Shannon-Lowe, Claire, Leese, Alison M., Fitzpatrick, Martin, Taylor, Graham S., Rickinson, Alan B.
Publicado 2016

Tracking immunodynamics by identification of S-G(2)/M-phase T cells in human peripheral blood()()

por Muñoz-Ruiz, Miguel, Pujol-Autonell, Irma, Rhys, Hefin, Long, Heather M., Greco, Maria, Peakman, Mark, Tree, Tim, Hayday, Adrian C., Di Rosa, Francesca
Publicado 2020

Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4(+) T Cells

por Meckiff, Benjamin J., Ladell, Kristin, McLaren, James E., Ryan, Gordon B., Leese, Alison M., James, Eddie A., Price, David A., Long, Heather M.
Publicado 2019

Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-tra...

por Offor, Ugonna T, Hollis, Paolo, Ognjanovic, Milos, Parry, Gareth, Khushnood, Abbas, Long, Heather M, Gennery, Andrew R, Bacon, Chris M, Simmonds, Jacob, Reinhardt, Zdenka, Bomken, Simon
Publicado 2023

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

por Burns, David M., Ryan, Gordon B., Harvey, Caroline M., Nagy, Eszter, Hughes, Simon, Murray, Paul G., Russell, Nigel H., Fox, Christopher P., Long, Heather M.
Publicado 2019

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

por Kelly, Gemma L., Long, Heather M., Stylianou, Julianna, Thomas, Wendy A., Leese, Alison, Bell, Andrew I., Bornkamm, Georg W., Mautner, Josef, Rickinson, Alan B., Rowe, Martin
Publicado 2009

MHC II tetramers visualize human CD4(+) T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

por Long, Heather M., Chagoury, Odette L., Leese, Alison M., Ryan, Gordon B., James, Eddie, Morton, Laura T., Abbott, Rachel J.M., Sabbah, Shereen, Kwok, William, Rickinson, Alan B.
Publicado 2013

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

por Tubb, Vanessa M., Schrikkema, Deborah S., Croft, Nathan P., Purcell, Anthony W., Linnemann, Carsten, Freriks, Manon R., Chen, Frederick, Long, Heather M., Lee, Steven P., Bendle, Gavin M.
Publicado 2018

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

por Abbott, Rachel J., Pachnio, Annette, Pedroza-Pacheco, Isabela, Leese, Alison M., Begum, Jusnara, Long, Heather M., Croom-Carter, Debbie, Stacey, Andrea, Moss, Paul A. H., Hislop, Andrew D., Borrow, Persephone, Rickinson, Alan B., Bell, Andrew I.
Publicado 2017

Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children

por Jayasooriya, Shamanthi, de Silva, Thushan I., Njie-jobe, Jainaba, Sanyang, Chilel, Leese, Alison M., Bell, Andrew I., McAulay, Karen A., Yanchun, Peng, Long, Heather M., Dong, Tao, Whittle, Hilton C., Rickinson, Alan B., Rowland-Jones, Sarah L., Hislop, Andrew D., Flanagan, Katie L.
Publicado 2015

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

por Zuo, Jianmin, Dowell, Alexander C., Pearce, Hayden, Verma, Kriti, Long, Heather M., Begum, Jusnara, Aiano, Felicity, Amin-Chowdhury, Zahin, Hallis, Bassam, Stapley, Lorrain, Borrow, Ray, Linley, Ezra, Ahmad, Shazaad, Parker, Ben, Horsley, Alex, Amirthalingam, Gayatri, Brown, Kevin, Ramsay, Mary E., Ladhani, Shamez, Moss, Paul
Publicado 2021

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

por Zuo, Jianmin, Dowell, Alexander C., Pearce, Hayden, Verma, Kriti, Long, Heather M., Begum, Jusnara, Aiano, Felicity, Amin-Chowdhury, Zahin, Hoschler, Katja, Brooks, Tim, Taylor, Stephen, Hewson, Jacqueline, Hallis, Bassam, Stapley, Lorrain, Borrow, Ray, Linley, Ezra, Ahmad, Shazaad, Parker, Ben, Horsley, Alex, Amirthalingam, Gayatri, Brown, Kevin, Ramsay, Mary E., Ladhani, Shamez, Moss, Paul
Publicado 2021